Apotex Health Plans C$1.2 Billion IPO Listing in Toronto
Apotex Health's planned C$1.2 billion Toronto IPO underscores strong demand for Canadian healthcare equities, with potential to lift the S&P/TSX Composite Index…
Apotex Health's planned C$1.2 billion Toronto IPO underscores strong demand for Canadian healthcare equities, with potential to lift the S&P/TSX Composite Index…
Big Caring, Malaysia’s top pharma retailer, targets a $750 million IPO, marking a major test for equity capital markets in the region.
Kardigan IPO filing marks a milestone in cardiovascular drug development, highlighting renewed investor interest in biotech innovations beyond oncology.
Nvidia billionaire and board member Mark Stevens gifts $175 million to launch a new Bay Area medical school integrating AI and technology,…
FDA Commissioner Marty Makary’s resignation throws the agency into turmoil, threatening drug approvals and pressuring biotech and healthcare stocks.
FDA gridlock clouds drug approval timelines, pressuring healthcare stocks and ETFs like XLV and IBB.